Targeting TIMP-1 in hepatic fibrosis with milk thistle flavonolignans: mechanistic evidence and prospects for gold nanoparticle delivery.

Macova R, Babelova A, Selc M

Open source

DOI
10.1152/ajpcell.90034.2026
Published
2026 Nov 1
Container
American journal of physiology. Cell physiology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1152/ajpcell.90034.2026,
  title = {Targeting TIMP-1 in hepatic fibrosis with milk thistle flavonolignans: mechanistic evidence and prospects for gold nanoparticle delivery.},
  author = {Macova R and Babelova A and Selc M},
  year = {2026},
  journal = {American journal of physiology. Cell physiology},
  doi = {10.1152/ajpcell.90034.2026},
  url = {https://doi.org/10.1152/ajpcell.90034.2026}
}

RIS

TY  - JOUR
TI  - Targeting TIMP-1 in hepatic fibrosis with milk thistle flavonolignans: mechanistic evidence and prospects for gold nanoparticle delivery.
AU  - Macova R
AU  - Babelova A
AU  - Selc M
PY  - 2026
JO  - American journal of physiology. Cell physiology
DO  - 10.1152/ajpcell.90034.2026
UR  - https://doi.org/10.1152/ajpcell.90034.2026
ER  - 

APA

R, M., A, B., & M, S. (2026). Targeting TIMP-1 in hepatic fibrosis with milk thistle flavonolignans: mechanistic evidence and prospects for gold nanoparticle delivery.. American journal of physiology. Cell physiology. https://doi.org/10.1152/ajpcell.90034.2026

Source records